首页> 外文期刊>Oncology letters >Histological evaluation of bone biopsy results during PVP or PKP of vertebral compression fractures
【24h】

Histological evaluation of bone biopsy results during PVP or PKP of vertebral compression fractures

机译:椎体压缩性骨折PVP或PKP期间骨活检结果的组织学评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP) is utilized for the treatment of vertebral compression fractures (VCFs). The present study was conducted to evaluate biopsy results obtained from VCFs during PVPor PKP. Between January 2003 and December 2011, 692 vertebral body biopsies were obtained from 546 patients (442 females and 104 males; mean age, 72.3 years), who underwent PVP or PKP for treatment of VCFs. A history of malignancy was identified in 44 patients. Histological/immunohistochemical evaluations were performed by experienced pathologists and 89.9% of biopsies obtained from 546 patients were suitable for histological/immunohistochemical evaluation. The biopsy results of 398 patients were in good agreement with the diagnosis of osteoporotic VCFs. Among the 44 patients with a history of malignancy, malignancy was identified in 25 patients, while osteoporosis was identified in 16 patients. Biopsies of the other 3 patients were not suitable for pathological examination. There were only 2 patients with previously undiagnosed malignancy. One patient was diagnosed with multiple myeloma, while another patient was diagnosed with metastatic carcinoma. In the present study, the rate of unsuspected malignancy was 0.4%. No symptomatic complications occurred as a result of biopsy. The results indicate that biopsy is safely performed during PVP or PKP and it is an efficacious procedure that verifies the pathological process and assists in identifying previously unsuspected processes responsible for VCFs. We recommend obtaining the biopsy of every collapsed vertebral body during PVP or PKP procedures.
机译:经皮椎体成形术(PVP)或经皮椎体后凸成形术(PKP)用于治疗椎体压缩性骨折(VCF)。进行本研究以评估在PVP或PKP期间从VCF获得的活检结果。在2003年1月至2011年12月之间,从546例患者(其中442例女性和104例男性;平均年龄72.3岁)中接受了692例椎体活检,这些患者接受了PVP或PKP治疗VCF。在44例患者中发现了恶性病史。组织学/免疫组织化学评估由经验丰富的病理学家进行,从546例患者中获得的活检样本中有89.9%适合组织学/免疫组织化学评估。 398例患者的活检结果与骨质疏松性VCF的诊断非常吻合。在有恶性病史的44例患者中,有25例被确认为恶性,而16例被确认为骨质疏松。其他3例患者的活检不适合进行病理检查。只有2例先前未被诊断出的恶性肿瘤。一名患者被诊断出患有多发性骨髓瘤,而另一名患者被诊断出患有转移性癌。在本研究中,意外恶性肿瘤的发生率为0.4%。活检未见有症状并发症发生。结果表明活检是在PVP或PKP期间安全进行的,它是一种有效的程序,可验证病理过程并帮助识别导致VCF的先前未曾怀疑的过程。我们建议在PVP或PKP手术期间对每个塌陷的椎体进行活检。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号